Star Equity Holdings Past Earnings Performance
Past criteria checks 0/6
Star Equity Holdings's earnings have been declining at an average annual rate of -8.6%, while the Healthcare industry saw earnings growing at 7% annually. Revenues have been declining at an average rate of 1.4% per year.
Key information
-8.6%
Earnings growth rate
29.1%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | -1.4% |
| Return on equity | -2.9% |
| Net Margin | -8.3% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Improved Revenues Required Before Star Equity Holdings, Inc. (NASDAQ:STRR) Stock's 25% Jump Looks Justified
Sep 13
Star Equity Holdings, Inc. (NASDAQ:STRR) Shares Could Be 45% Below Their Intrinsic Value Estimate
Aug 15Star Equity Holdings (NASDAQ:STRR) Has Debt But No Earnings; Should You Worry?
Mar 16Is Star Equity Holdings (NASDAQ:STRR) Weighed On By Its Debt Load?
Nov 12Star Equity Holdings Q2 2022 Earnings Preview
Aug 11Earnings Release: Here's Why Analysts Cut Their Star Equity Holdings, Inc. (NASDAQ:STRR) Price Target To US$5.75
Mar 24A Look At The Intrinsic Value Of Star Equity Holdings, Inc. (NASDAQ:STRR)
Nov 19We Think Star Equity Holdings (NASDAQ:STRR) Has A Fair Chunk Of Debt
Jul 26Time To Worry? Analysts Are Downgrading Their Star Equity Holdings, Inc. (NASDAQ:STRR) Outlook
Mar 11Analysts Expect Breakeven For Star Equity Holdings, Inc. (NASDAQ:STRR) Before Long
Jan 26
Digirad will now be called Star Equity Holdings
Dec 28How Much Is Digirad Corporation (NASDAQ:DRAD) Paying Its CEO?
Dec 05Digirad EPS misses by $0.34, misses on revenue
Nov 13Digirad rallies after hours on selling DMS Health for $18.75M
Nov 03Revenue & Expenses BreakdownBeta
How Star Equity Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 46 | -4 | 15 | 0 |
| 30 Sep 23 | 104 | -4 | 29 | 0 |
| 30 Jun 23 | 105 | -3 | 28 | 0 |
| 31 Mar 23 | 113 | -3 | 27 | 0 |
| 31 Dec 22 | 57 | -8 | 14 | 0 |
| 30 Sep 22 | 69 | -13 | 17 | 0 |
| 30 Jun 22 | 87 | -14 | 19 | 0 |
| 31 Mar 22 | 96 | -15 | 21 | 0 |
| 31 Dec 21 | 107 | -11 | 23 | 0 |
| 30 Sep 21 | 100 | -7 | 21 | 0 |
| 30 Jun 21 | 93 | -6 | 21 | 0 |
| 31 Mar 21 | 81 | -5 | 19 | 0 |
| 31 Dec 20 | 78 | -7 | 19 | 0 |
| 30 Sep 20 | 50 | -5 | 14 | 0 |
| 30 Jun 20 | 57 | -4 | 15 | 0 |
| 31 Mar 20 | 68 | -5 | 16 | 0 |
| 31 Dec 19 | 73 | -3 | 16 | 0 |
| 30 Sep 19 | 104 | -6 | 19 | 0 |
| 30 Jun 19 | 101 | -5 | 19 | 0 |
| 31 Mar 19 | 103 | -4 | 19 | 0 |
| 31 Dec 18 | 104 | -4 | 20 | 0 |
| 30 Sep 18 | 105 | -26 | 21 | 0 |
| 30 Jun 18 | 105 | -32 | 22 | 0 |
| 31 Mar 18 | 104 | -34 | 23 | 0 |
| 31 Dec 17 | 105 | -35 | 23 | 0 |
| 30 Sep 17 | 109 | -10 | 24 | 0 |
| 30 Jun 17 | 115 | -3 | 26 | 0 |
| 31 Mar 17 | 120 | 0 | 27 | 0 |
| 31 Dec 16 | 125 | 14 | 28 | 0 |
| 30 Sep 16 | 110 | 13 | 26 | 0 |
| 30 Jun 16 | 95 | 32 | 22 | 0 |
| 31 Mar 16 | 78 | 33 | 18 | 0 |
| 31 Dec 15 | 61 | 22 | 13 | 0 |
| 30 Sep 15 | 59 | 22 | 13 | 0 |
| 30 Jun 15 | 57 | 4 | 13 | 0 |
| 31 Mar 15 | 56 | 3 | 13 | 0 |
| 31 Dec 14 | 56 | 2 | 13 | 0 |
| 30 Sep 14 | 54 | 2 | 13 | 0 |
| 30 Jun 14 | 53 | 4 | 12 | 0 |
| 31 Mar 14 | 51 | 3 | 12 | 0 |
| 31 Dec 13 | 49 | 0 | 13 | 1 |
| 30 Sep 13 | 50 | -2 | 13 | 2 |
| 30 Jun 13 | 49 | -6 | 14 | 3 |
Quality Earnings: STRR is currently unprofitable.
Growing Profit Margin: STRR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: STRR is unprofitable, and losses have increased over the past 5 years at a rate of 8.6% per year.
Accelerating Growth: Unable to compare STRR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: STRR is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (9.2%).
Return on Equity
High ROE: STRR has a negative Return on Equity (-2.92%), as it is currently unprofitable.